Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · IEX Real-Time Price · USD
3.110
+0.270 (9.51%)
May 8, 2024, 10:12 AM EDT - Market open
Cyclerion Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
7.59M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 297.00K | -3.65M | -92.47% |
Dec 31, 2021 | 3.94M | 1.65M | 71.69% |
Dec 31, 2020 | 2.30M | -2.21M | -49.06% |
Dec 31, 2019 | 4.51M | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCYCN News
- 5 months ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire
- 5 months ago - Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - GlobeNewsWire
- 10 months ago - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - GlobeNewsWire
- 1 year ago - Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Cyclerion Announces Reverse Stock Split - GlobeNewsWire
- 1 year ago - Cyclerion Announces Definitive Agreement for Zagociguat and CY3018 - GlobeNewsWire
- 1 year ago - Cyclerion Announces Corporate Updates and Q1 2023 Financial Results - GlobeNewsWire
- 1 year ago - Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement - GlobeNewsWire